Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.6% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
3
users have commented on this narrative
45
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
0
users have commented on this narrative
17
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.3% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
17
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
ADTRAN Holdings
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
Exponential Global Data Demand Will Expand Fiber Network Opportunities
Key Takeaways Ongoing market share gains, AI-driven software innovation, and strong broadband demand are fueling revenue growth and expanding ADTRAN's total addressable market. Portfolio expansion into software-defined and secure networking, paired with operational discipline, is set to drive recurring revenue and rapid cash flow improvement.
View narrative
US$15.00
FV
41.1% undervalued
intrinsic discount
14.09%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Riskified
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
E-commerce And AI Will Redefine Fraud Prevention
Key Takeaways Accelerating product adoption and advanced AI-driven fraud solutions position Riskified for outsized revenue growth, market share gains, and superior merchant retention. Multiyear contracts, region-leading expansion, and buybacks signal underestimated margin expansion and durable earnings outperformance relative to peers.
View narrative
US$8.00
FV
34.3% undervalued
intrinsic discount
10.22%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
FIP
FTAI Infrastructure
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Rising US Infrastructure Spending Will Transform Freight Networks
Key Takeaways Transformative acquisitions and underestimated project expansions position the company for rapid revenue growth, margin gains, and improving long-term free cash flow. Strategic scale, industry trends, and green infrastructure demand set the stage for dominant market positioning and durable, recurring revenue expansion.
View narrative
US$13.00
FV
63.8% undervalued
intrinsic discount
55.24%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
indie Semiconductor
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
EV And ADAS Adoption Will Expand Sensor Opportunities
Key Takeaways Software licensing and new ADAS products could deliver recurring, high-margin revenue and rapid gross profit growth, surpassing current market expectations. Early moves in photonics, quantum, and new industrial verticals position the company to unlock transformative value across multiple markets beyond automotive.
View narrative
US$7.96
FV
43.2% undervalued
intrinsic discount
28.91%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
AbCellera Biologics
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
AI Integration And Internal Pipeline Will Accelerate Biologics Growth
Key Takeaways Innovative trial execution, distinctive product features, and AI-driven antibody discovery position AbCellera to quickly gain market share and attract significant partner interest. Efficient R&D investment, advanced manufacturing, and growing internal pipeline set the stage for improved profitability and outsized long-term royalty and milestone revenues.
View narrative
US$16.43
FV
72.1% undervalued
intrinsic discount
95.22%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Digimarc
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
EU Green Deal And Smart Packaging Will Transform Supply Chains
Key Takeaways Deep industry integration and regulatory shifts are set to drive outsized adoption, recurring revenues, and rapid operating leverage for Digimarc. Unique technology and strategic partnerships position Digimarc as a foundational player in digital authentication, supply chain transparency, and smart packaging innovation.
View narrative
US$30.00
FV
70.6% undervalued
intrinsic discount
-3.59%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Brandywine Realty Trust
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
Sun Belt Growth And Life Sciences Will Fuel Office Demand
Key Takeaways Favorable leasing trends and asset recapitalization position Brandywine for strong revenue and earnings growth, with potential to exceed current market expectations. Strategic focus on high-demand regions and mixed-use, energy-efficient properties supports occupancy, pricing power, and above-average long-term profitability.
View narrative
US$6.00
FV
33.0% undervalued
intrinsic discount
21.66%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Zymeworks
AN
AnalystHighTarget
Consensus Narrative from 9 Analysts
Targeted Biologic Therapies Will Serve An Aging World
Key Takeaways Proprietary antibody and ADC platforms, strong partnerships, and AI-driven discovery position Zymeworks for compounding growth in targeted therapies and market expansion. Multiple high-value assets, strategic deals, and efficient development create sustained upside, superior returns, and resilience in a consolidating biopharma landscape.
View narrative
US$30.00
FV
52.1% undervalued
intrinsic discount
22.67%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Trulieve Cannabis
AN
AnalystHighTarget
Consensus Narrative from 8 Analysts
Legalization And Wellness Integration Will Fuel Cannabis Industry Transformation
Key Takeaways Market dominance, operational agility, and early mainstream expansion position Trulieve for outpaced growth as legalization advances in key states. Vertical integration and strong liquidity support sector-leading margin expansion, strategic acquisitions, and efficient national scaling as regulations evolve.
View narrative
CA$27.15
FV
61.7% undervalued
intrinsic discount
1.46%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Value any company in seconds
Popular companies